Concepts (120)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Receptor for Advanced Glycation End Products | 5 | 2020 | 25 | 2.470 |
Why?
|
| Caenorhabditis elegans | 7 | 2020 | 223 | 1.760 |
Why?
|
| Glycation End Products, Advanced | 3 | 2018 | 20 | 1.700 |
Why?
|
| Neurodegenerative Diseases | 3 | 2018 | 251 | 1.370 |
Why?
|
| Tendon Injuries | 1 | 2023 | 20 | 0.840 |
Why?
|
| Teratogens | 6 | 2011 | 87 | 0.690 |
Why?
|
| Models, Animal | 5 | 2018 | 467 | 0.680 |
Why?
|
| Chlorpyrifos | 3 | 2015 | 3 | 0.630 |
Why?
|
| Metals | 1 | 2018 | 61 | 0.590 |
Why?
|
| Perfume | 1 | 2017 | 2 | 0.590 |
Why?
|
| Phthalic Acids | 1 | 2017 | 7 | 0.580 |
Why?
|
| Neurons | 6 | 2018 | 1933 | 0.580 |
Why?
|
| Fatty Acids, Monounsaturated | 1 | 2017 | 47 | 0.570 |
Why?
|
| Neurotoxins | 1 | 2017 | 56 | 0.560 |
Why?
|
| Muscle, Skeletal | 1 | 2023 | 931 | 0.540 |
Why?
|
| Hyperglycemia | 1 | 2018 | 221 | 0.540 |
Why?
|
| Caenorhabditis elegans Proteins | 1 | 2016 | 89 | 0.520 |
Why?
|
| Insecticides | 2 | 2015 | 39 | 0.510 |
Why?
|
| Allergens | 1 | 2017 | 244 | 0.490 |
Why?
|
| Glucose | 2 | 2020 | 876 | 0.480 |
Why?
|
| Fluorocarbons | 3 | 2009 | 57 | 0.480 |
Why?
|
| Mesenchymal Stem Cell Transplantation | 1 | 2015 | 78 | 0.470 |
Why?
|
| Neurotoxicity Syndromes | 2 | 2018 | 47 | 0.460 |
Why?
|
| Forkhead Transcription Factors | 1 | 2016 | 371 | 0.460 |
Why?
|
| Models, Theoretical | 1 | 2016 | 349 | 0.450 |
Why?
|
| Neurogenesis | 1 | 2015 | 196 | 0.430 |
Why?
|
| Oxidative Stress | 1 | 2018 | 803 | 0.420 |
Why?
|
| Disease Models, Animal | 5 | 2018 | 4308 | 0.420 |
Why?
|
| Caprylates | 2 | 2009 | 12 | 0.420 |
Why?
|
| Dopamine | 3 | 2018 | 273 | 0.390 |
Why?
|
| Insulin | 1 | 2016 | 1190 | 0.380 |
Why?
|
| Inflammation | 1 | 2018 | 1399 | 0.370 |
Why?
|
| Alkanesulfonic Acids | 1 | 2009 | 10 | 0.340 |
Why?
|
| Chick Embryo | 5 | 2015 | 131 | 0.330 |
Why?
|
| Animals | 18 | 2022 | 33911 | 0.310 |
Why?
|
| Brain | 3 | 2015 | 2955 | 0.260 |
Why?
|
| Prenatal Exposure Delayed Effects | 3 | 2022 | 224 | 0.260 |
Why?
|
| Toxicity Tests | 3 | 2018 | 36 | 0.260 |
Why?
|
| Stem Cell Transplantation | 3 | 2010 | 239 | 0.220 |
Why?
|
| Tendon Transfer | 1 | 2023 | 3 | 0.210 |
Why?
|
| Wrist Joint | 1 | 2023 | 23 | 0.210 |
Why?
|
| Wrist | 1 | 2023 | 24 | 0.210 |
Why?
|
| Animals, Genetically Modified | 2 | 2020 | 316 | 0.180 |
Why?
|
| Cadmium Poisoning | 1 | 2020 | 3 | 0.180 |
Why?
|
| Manganese Poisoning | 1 | 2020 | 3 | 0.180 |
Why?
|
| Serotonergic Neurons | 1 | 2020 | 21 | 0.180 |
Why?
|
| Dopaminergic Neurons | 1 | 2020 | 49 | 0.170 |
Why?
|
| Nerve Degeneration | 1 | 2020 | 126 | 0.160 |
Why?
|
| Abnormalities, Drug-Induced | 2 | 2010 | 90 | 0.160 |
Why?
|
| Heat-Shock Response | 1 | 2018 | 31 | 0.150 |
Why?
|
| Central Nervous System Depressants | 1 | 2018 | 24 | 0.150 |
Why?
|
| Acetylcholine | 1 | 2018 | 83 | 0.150 |
Why?
|
| Locomotion | 1 | 2018 | 69 | 0.150 |
Why?
|
| Chickens | 4 | 2011 | 637 | 0.140 |
Why?
|
| Glutamic Acid | 1 | 2018 | 200 | 0.140 |
Why?
|
| Ethanol | 1 | 2018 | 160 | 0.140 |
Why?
|
| Reproduction | 1 | 2018 | 239 | 0.130 |
Why?
|
| Maze Learning | 3 | 2011 | 127 | 0.130 |
Why?
|
| Organophosphates | 1 | 2015 | 13 | 0.130 |
Why?
|
| Gene Expression | 2 | 2022 | 1592 | 0.120 |
Why?
|
| Serotonin | 1 | 2015 | 221 | 0.110 |
Why?
|
| Embryo, Nonmammalian | 2 | 2011 | 142 | 0.110 |
Why?
|
| Protein Kinase C | 2 | 2009 | 151 | 0.100 |
Why?
|
| Behavior, Animal | 2 | 2011 | 477 | 0.100 |
Why?
|
| Plasticizers | 1 | 2011 | 2 | 0.100 |
Why?
|
| Diethylhexyl Phthalate | 1 | 2011 | 5 | 0.100 |
Why?
|
| Dibutyl Phthalate | 1 | 2011 | 4 | 0.100 |
Why?
|
| Humans | 7 | 2023 | 122517 | 0.100 |
Why?
|
| Attention Deficit and Disruptive Behavior Disorders | 1 | 2011 | 44 | 0.090 |
Why?
|
| Telencephalon | 1 | 2009 | 8 | 0.090 |
Why?
|
| Neural Stem Cells | 1 | 2011 | 126 | 0.090 |
Why?
|
| Sarin | 1 | 2009 | 1 | 0.080 |
Why?
|
| Intracellular Membranes | 1 | 2009 | 64 | 0.080 |
Why?
|
| Chemical Warfare Agents | 1 | 2009 | 6 | 0.080 |
Why?
|
| Time | 1 | 2009 | 91 | 0.080 |
Why?
|
| Nootropic Agents | 1 | 2009 | 25 | 0.080 |
Why?
|
| Cytosol | 1 | 2009 | 160 | 0.080 |
Why?
|
| Isoenzymes | 1 | 2009 | 223 | 0.080 |
Why?
|
| Embryonic Stem Cells | 1 | 2010 | 172 | 0.080 |
Why?
|
| Cell Culture Techniques | 1 | 2010 | 288 | 0.080 |
Why?
|
| Protein Transport | 1 | 2009 | 369 | 0.080 |
Why?
|
| Nicotine | 1 | 2009 | 140 | 0.080 |
Why?
|
| Pigmentation | 1 | 2008 | 36 | 0.070 |
Why?
|
| Hindlimb | 1 | 2008 | 75 | 0.070 |
Why?
|
| Environmental Pollutants | 1 | 2008 | 68 | 0.070 |
Why?
|
| Cerebral Cortex | 1 | 2009 | 448 | 0.060 |
Why?
|
| Cognition Disorders | 1 | 2009 | 555 | 0.060 |
Why?
|
| Heroin | 1 | 2022 | 19 | 0.050 |
Why?
|
| Cadmium Chloride | 1 | 2020 | 4 | 0.050 |
Why?
|
| Manganese Compounds | 1 | 2020 | 9 | 0.040 |
Why?
|
| Chlorides | 1 | 2020 | 104 | 0.040 |
Why?
|
| Pregnancy | 3 | 2022 | 7123 | 0.040 |
Why?
|
| Species Specificity | 1 | 2018 | 552 | 0.040 |
Why?
|
| Female | 6 | 2022 | 65064 | 0.030 |
Why?
|
| Mice | 4 | 2022 | 17646 | 0.030 |
Why?
|
| Hippocampus | 1 | 2022 | 810 | 0.030 |
Why?
|
| Hernia, Umbilical | 1 | 2011 | 42 | 0.020 |
Why?
|
| Gastroschisis | 1 | 2011 | 53 | 0.020 |
Why?
|
| Cerebral Ventricles | 1 | 2011 | 81 | 0.020 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2010 | 54 | 0.020 |
Why?
|
| Cerebrum | 1 | 2010 | 32 | 0.020 |
Why?
|
| Choline O-Acetyltransferase | 1 | 2009 | 13 | 0.020 |
Why?
|
| Acetylcholinesterase | 1 | 2009 | 20 | 0.020 |
Why?
|
| Epidermal Growth Factor | 1 | 2010 | 122 | 0.020 |
Why?
|
| Oligodendroglia | 1 | 2010 | 84 | 0.020 |
Why?
|
| Brain Tissue Transplantation | 1 | 2009 | 3 | 0.020 |
Why?
|
| Transplantation, Homologous | 1 | 2011 | 660 | 0.020 |
Why?
|
| Fetal Tissue Transplantation | 1 | 2009 | 16 | 0.020 |
Why?
|
| Risk Assessment | 1 | 2018 | 3307 | 0.020 |
Why?
|
| Random Allocation | 1 | 2009 | 415 | 0.020 |
Why?
|
| DNA Damage | 1 | 2011 | 517 | 0.020 |
Why?
|
| Membrane Transport Proteins | 1 | 2009 | 176 | 0.020 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2009 | 90 | 0.020 |
Why?
|
| Astrocytes | 1 | 2010 | 251 | 0.020 |
Why?
|
| Embryonic Development | 1 | 2008 | 208 | 0.020 |
Why?
|
| Dose-Response Relationship, Drug | 1 | 2009 | 1687 | 0.020 |
Why?
|
| Aging | 1 | 2009 | 1170 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 2010 | 1935 | 0.010 |
Why?
|
| Adult | 1 | 2022 | 28800 | 0.010 |
Why?
|
| Male | 2 | 2009 | 59687 | 0.010 |
Why?
|